Skip to content

Clinical trials

Phase 2 Epilepsies, Partial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Partial Phase: Phase 2 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20072
20091
20101
20114
20131
20191
20202
20221
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Recruiting3
Withdrawn2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Marinus Pharmaceuticals2
National Institute of Neurological Disorders and Stroke (NINDS)2
Rapport Therapeutics Inc.2
SK Life Science, Inc.2
Supernus Pharmaceuticals, Inc.2
UCB Pharma2
Biohaven Therapeutics Ltd.1
Emory University1
Engrail Therapeutics INC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Partial23
Epilepsy12
Seizures11
Drug Resistant Epilepsy2
Epilepsy, Temporal Lobe2
Anxiety Disorders1
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Limbic Encephalitis1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.